Identifying prognostic factors in patients with radioiodine-refractory differentiated thyroid carcinoma (RR-DTC) treated with tyrosine kinase inhibitors (TKI): Data from REGETNE registry-MedSci.cn

Identifying prognostic factors in patients with radioiodine-refractory differentiated thyroid carcinoma (RR-DTC) treated with tyrosine kinase inhibitors (TKI): Data from REGETNE registry

Gil, MVSR; Hernando, J; Granados, AR; Carmona, A; Ospina, GM; Bella, MR; Castelo, B; Ramirez, SEC; Cerrillo, JM; Ruz-Caracuel, I; Valderrabano, P; Pierrard, PL; Herrera, MR; Alvarez, AG; Perez, JP; Merino, CG; Gordoa, TA; Castillon, JC

ANNALS OF ONCOLOGY, 2023; 34 (): S1146

科室
- - 订阅+
  - 更多科室
工具
服务